Posted in | News | Iron Ore | Mining Business

Nunavut Extends Offer for Baffinland

Nunavut Iron Ore has taken yet another step in the bidding war against ArcelorMittal for Baffinland Iron Mines. It has raised its offer to Canadian $1.45 in cash per share in addition to one exchange right per common share.

Baffinland shareholders can also buy one common share over the next three years at $1.40 or a price set by the Toronto Stock Exchange rules. It has also extended its offer to January 25, 2011. The bidding war for Baffinland Iron Mines has been in progress since September last year.

The last offer made by the world’s largest steelmaking company ArcelorMittal was C$1.40 per share bid for 100 percent of the company. This offer is set to expire on Monday and has not been extended so far. Baffinland Iron Mines owns the Mary River iron ore deposit in the Eastern Arctic Baffin Island.

The new offer by Nunavut is being seen as a pressure tactic in the proceedings by analysts. The Monday deadline will no longer be as effective for Baffinland shareholders as they now have an option to go with Nunavut at a later date. Nunavut at present has a 10% stake in Baffinland.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Baffinland Iron Mines Corporation. (2019, February 18). Nunavut Extends Offer for Baffinland. AZoMining. Retrieved on April 19, 2024 from https://www.azomining.com/News.aspx?newsID=2454.

  • MLA

    Baffinland Iron Mines Corporation. "Nunavut Extends Offer for Baffinland". AZoMining. 19 April 2024. <https://www.azomining.com/News.aspx?newsID=2454>.

  • Chicago

    Baffinland Iron Mines Corporation. "Nunavut Extends Offer for Baffinland". AZoMining. https://www.azomining.com/News.aspx?newsID=2454. (accessed April 19, 2024).

  • Harvard

    Baffinland Iron Mines Corporation. 2019. Nunavut Extends Offer for Baffinland. AZoMining, viewed 19 April 2024, https://www.azomining.com/News.aspx?newsID=2454.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.